TEVA PHARMACEUTICAL INDUSTRIES LTD — Form 10-Q

On July 28, 2026, Teva's Board amended and restated its 2008 Employee Stock Purchase Plan for U.S. employees. The amendment increases authorized shares by 8,500,000 (bringing total to 9,082,705 shares available under the plan), extends the plan term through July 28, 2036 (ten years from amendment date), and provides for conversion of ADSs to Ordinary Shares upon termination of the ADS program. The amendment is contingent on shareholder approval within 12 months; if not approved, the plan reverts to its prior version and may be terminated entirely.